Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Japanese Journal of Complementary and Alternative Medicine ; : 121-125, 2018.
Article in English | WPRIM | ID: wpr-688419

ABSTRACT

Peucedanum japonicum Thunb (PJT) has reported the effect of lipid and glucose metabolism at some in vivo and in vitro study. In this study, 21 subjects with dyslipidemia border zone took PJT for 12 weeks. The changes over time of body composition and biochemical test were examined. The values of HbA1c were significantly reduced compared to the values before intake. For body fat percentage, the value at 8 weeks after intake showed a significant decrease compared with the value before intake. Adiponectin was significantly increase after 8 weeks in obese subject. These results suggested PJT may improvement of glucose metabolism.

2.
The Korean Journal of Pain ; : 98-103, 2017.
Article in English | WPRIM | ID: wpr-192937

ABSTRACT

BACKGROUND: The root of Peucedanum japonicum Thunb., a perennial herb found in Japan, the Philippines, China, and Korea, is used as an analgesic. In a previous study, sec-O-glucosylhamaudol (SOG) showed an analgesic effect. This study was performed to examine the antinociceptive effect of intrathecal SOG in the formalin test. METHODS: Male Sprague-Dawley rats were implanted with an intrathecal catheter. Rats were randomly treated with a vehicle and SOG (10 µg, 30 µg, 60 µg, and 100 µg) before formalin injection. Five percent formalin was injected into the hind-paw, and a biphasic reaction followed, consisting of flinching and licking behaviors (phase 1, 0–10 min; phase 2, 10–60 min). Naloxone was injected 10 min before administration of SOG 100 µg to evaluate the involvement of SOG with an opioid receptor. Dose-responsiveness and ED50 values were calculated. RESULTS: Intrathecal SOG showed a significant reduction of the flinching responses at both phases in a dose-dependent manner. Significant effects were showed from the dose of 30 µg and maximum effects were achieved at a dose of 100 µg in both phases. The ED50 value (95% confidence intervals) of intrathecal SOG was 30.3 (25.8–35.5) µg during phase 1, and 48.0 (41.4–55.7) during phase 2. The antinociceptive effects of SOG (100 µg) were significantly reverted at both phases of the formalin test by naloxone. CONCLUSIONS: These results demonstrate that intrathecal SOG has a very strong antinociceptive effect in the formalin test and it seems the effect is related to an opioid receptor.


Subject(s)
Animals , Humans , Male , Rats , Analgesia , Catheters , China , Formaldehyde , Japan , Korea , Naloxone , Nociception , Pain Measurement , Philippines , Rats, Sprague-Dawley , Receptors, Opioid
SELECTION OF CITATIONS
SEARCH DETAIL